PAMELA KINNEY: Open Payments
NPI 1023618535 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 34 payments from 15 companies in 2025. Trend: 2023 $436 · 2024 $946 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $271 |
| AstraZeneca Pharmaceuticals LP | 4 | $242 |
| REVANCE THERAPEUTICS, INC. | 3 | $230 |
| Corcept Therapeutics | 3 | $135 |
| Lilly USA, LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: DAXXIFY, AIRSUPRA, Korlym, BOTOX, VRAYLAR, FARXIGA, UBRELVY, REXULTI.
Industry payments across KY — which companies pay providers there.
